Vitaly N Kustarov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vitaly N Kustarov has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Irina Yevgenyevna Zazerskaya
V.A. Almazov National Medical Research Center
3 shared publications Almazov National Medical Research Centre
1 shared publication- Anna A. Kuznetsova
Almazov National Medical Research Centre
1 shared publication - Arutyun Felixovich Arutyunyan
Sertolovskaya City Hospital
1 shared publication - E.S. Shelepova1 shared publication
- Godzoeva A.O. Godzoeva1 shared publication
Latest Publications
- 1 January 2025
- Published by NP Rusmedical Group in Women's Health and Reproduction
- Vol. 69 (4)
Prognostic risk factors for abnormally adherent and invasive placenta in women with placenta located in the area of the uterine scar
Aim. To identify independent prognostic risk factors for abnormally adherent and invasive placenta (AAIP) in women with a placenta located in the area of a uterine scar. Design. Case-control study. Materials and methods. A study was conducted involving 110 women with placenta located in the area of a uterine scar, divided into two groups: the main group with placenta located in the area of the uterine scar and abnormally adherent and invasive placenta (AAIP) (n = 55) and the control group with placenta located in the area of the uterine scar without AAIP (n = 55). A retrospective analysis was performed using medical records, general and obstetric examination data, and information collected during pregnancy and at the time of hospitalization for delivery. Statistical analysis methods were used to identify significant factors. Results. Despite comparable obstetric and gynecological history, the key prognostic factors for AAIP were features of the current pregnancy: placenta previa (odds ratio (OR) = 70.7; 95% confidence interval (CI) 15.3–326.8); vaginal bleeding after 26 weeks of gestation (OR = 5.7; 95% CI 2.47–12.97); threatened late miscarriage/preterm birth in the 2nd and 3rd trimesters (OR = 4.3 and 3.5, respectively); anemia diagnosed in the 2nd trimester (OR = 2.66; 95% CI 1.2–6.1). Conclusion. In women with placenta located in the area of the uterine scar, in addition to placenta previa, independent prognostic risk factors for AAIP are late-pregnancy bleeding, threatened preterm birth in the 2nd–3rd trimesters, and 2nd-trimester anemia. The establishment of these features will improve the prenatal detection of high-risk patients. Keywords: abnormally adherent and invasive placenta, placenta located in the uterine scar, risk factors, placenta previa, obstetric hemorrhage.
- 1 January 2025
- Published by NP Rusmedical Group in Women's Health and Reproduction
- Vol. 69 (4)
Prognostic risk factors for abnormally adherent and invasive placenta in women with placenta located in the area of the uterine scar
Aim. To identify independent prognostic risk factors for abnormally adherent and invasive placenta (AAIP) in women with a placenta located in the area of a uterine scar. Design. Case-control study. Materials and methods. A study was conducted involving 110 women with placenta located in the area of a uterine scar, divided into two groups: the main group with placenta located in the area of the uterine scar and abnormally adherent and invasive placenta (AAIP) (n = 55) and the control group with placenta located in the area of the uterine scar without AAIP (n = 55). A retrospective analysis was performed using medical records, general and obstetric examination data, and information collected during pregnancy and at the time of hospitalization for delivery. Statistical analysis methods were used to identify significant factors. Results. Despite comparable obstetric and gynecological history, the key prognostic factors for AAIP were features of the current pregnancy: placenta previa (odds ratio (OR) = 70.7; 95% confidence interval (CI) 15.3–326.8); vaginal bleeding after 26 weeks of gestation (OR = 5.7; 95% CI 2.47–12.97); threatened late miscarriage/preterm birth in the 2nd and 3rd trimesters (OR = 4.3 and 3.5, respectively); anemia diagnosed in the 2nd trimester (OR = 2.66; 95% CI 1.2–6.1). Conclusion. In women with placenta located in the area of the uterine scar, in addition to placenta previa, independent prognostic risk factors for AAIP are late-pregnancy bleeding, threatened preterm birth in the 2nd–3rd trimesters, and 2nd-trimester anemia. The establishment of these features will improve the prenatal detection of high-risk patients. Keywords: abnormally adherent and invasive placenta, placenta located in the uterine scar, risk factors, placenta previa, obstetric hemorrhage.
- Open Access
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 24 (1)
Somatic Risk Factors for the Development of Preeclampsia in Pregnant Women with Previous COVID-19
Aim. To assess the contribution of somatic factors to the development of preeclampsia in pregnant women with previous coronavirus infection. Design. Retrospective cohort study. Materials and methods. The main group included 48 patients who gave birth at the Almazov National Medical Research Centre in 2022, with confirmed coronavirus infection during pregnancy at any gestational age, and with a subsequently established diagnosis of preeclampsia. Comparison Group No. 1 is a simple random sample of 70 patients who gave birth at the Almazov National Medical Research Centre in the same period, with a history of coronavirus infection without preeclampsia. Comparison Group No. 2 included 70 patients with preeclampsia who gave birth in 2019 (before the pandemic). A retrospective analysis of the pregnancy course and outcomes, anamnestic, laboratory and instrumental data was carried out. Results. Significant somatic risk factors for the development of preeclampsia after coronavirus infection include obesity, the frequency of which among patients in the main group was 47.9% (23/48) versus 20% (14/70) in comparison group No. 1 and 27.1% (19/70) in comparison group No. 2 (p = 0.005), as well as diabetes mellitus (10.4% (5/48) in the main group, 4.3% (3/70) in comparison group No. 2; there were no patients with diabetes mellitus in comparison group No. 1; p = 0.019). In addition, the somatic history of patients with preeclampsia and COVID-19 was characterized by a higher frequency of respiratory diseases comparing with other groups: 7 (14.6%) out of 48 patients in the main group, 2 (2.9%) women each in comparison groups No. 1 and No. 2 (p = 0.02). In the structure of somatic pathology in patients from the groups with preeclampsia (main group and comparison group No. 2), chronic arterial hypertension was also a significant risk factor, regardless of the fact of previous coronavirus infection. With regard to other pathologies of the cardiovascular system, rheumatic and gastrointestinal diseases, pathology of nervous and urinary systems, infectious and inflammatory diseases of non-coronavirus etiology, venous thromboembolic complications and blood diseases, significant differences between the groups were not established (p > 0.05). Conclusion. In patients with previous coronavirus infection, the most significant risk factors for preeclampsia were obesity, diabetes mellitus, and respiratory diseases. Large population studies are needed to develop the correct tactics for managing such patients from the high-risk group for gestational complications. Keywords: preeclampsia, COVID-19, coronavirus infection, arterial hypertension, obesity, diabetes mellitus, respiratory diseases.
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 24 (1)
Open AccessSomatic Risk Factors for the Development of Preeclampsia in Pregnant Women with Previous COVID-19
Aim. To assess the contribution of somatic factors to the development of preeclampsia in pregnant women with previous coronavirus infection. Design. Retrospective cohort study. Materials and methods. The main group included 48 patients who gave birth at the Almazov National Medical Research Centre in 2022, with confirmed coronavirus infection during pregnancy at any gestational age, and with a subsequently established diagnosis of preeclampsia. Comparison Group No. 1 is a simple random sample of 70 patients who gave birth at the Almazov National Medical Research Centre in the same period, with a history of coronavirus infection without preeclampsia. Comparison Group No. 2 included 70 patients with preeclampsia who gave birth in 2019 (before the pandemic). A retrospective analysis of the pregnancy course and outcomes, anamnestic, laboratory and instrumental data was carried out. Results. Significant somatic risk factors for the development of preeclampsia after coronavirus infection include obesity, the frequency of which among patients in the main group was 47.9% (23/48) versus 20% (14/70) in comparison group No. 1 and 27.1% (19/70) in comparison group No. 2 (p = 0.005), as well as diabetes mellitus (10.4% (5/48) in the main group, 4.3% (3/70) in comparison group No. 2; there were no patients with diabetes mellitus in comparison group No. 1; p = 0.019). In addition, the somatic history of patients with preeclampsia and COVID-19 was characterized by a higher frequency of respiratory diseases comparing with other groups: 7 (14.6%) out of 48 patients in the main group, 2 (2.9%) women each in comparison groups No. 1 and No. 2 (p = 0.02). In the structure of somatic pathology in patients from the groups with preeclampsia (main group and comparison group No. 2), chronic arterial hypertension was also a significant risk factor, regardless of the fact of previous coronavirus infection. With regard to other pathologies of the cardiovascular system, rheumatic and gastrointestinal diseases, pathology of nervous and urinary systems, infectious and inflammatory diseases of non-coronavirus etiology, venous thromboembolic complications and blood diseases, significant differences between the groups were not established (p > 0.05). Conclusion. In patients with previous coronavirus infection, the most significant risk factors for preeclampsia were obesity, diabetes mellitus, and respiratory diseases. Large population studies are needed to develop the correct tactics for managing such patients from the high-risk group for gestational complications. Keywords: preeclampsia, COVID-19, coronavirus infection, arterial hypertension, obesity, diabetes mellitus, respiratory diseases.
- 21 September 2020
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 9_2020
Fibrin monomer and D-dimer in infertile women undergoing assisted reproductive technology
- 21 September 2020
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 9_2020
Fibrin monomer and D-dimer in infertile women undergoing assisted reproductive technology
- Open Access
- 15 September 2016
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 7 (3) , 92-97
Contemporary aspects of pathogenetically substantiated therapy of adenomyosis
The purpose of our study was to assess the effectiveness of the use of drugs containing indole-3-carbinol and epigallocatechin-3 gallate in combination with effective natural methods (TES-therapy and hirudotherapy) depending on the degree of morphological adenomyosis. The study involved 205 women with diffuse adenomyosis. Based on survey data from 205 women surveyed in 67 verified adenomyosis first degree (Group 1), 79 - second degree adenomyosis (group 2), and 59 - third degree adenomyosis (group 3). Doppler results showed that in patients with adenomyosis first degree nizkorezistentny uterine blood flow was observed. Improvement of clinical symptoms of the disease, increasing the numerical values of R & D in the uterine arteries at the first degree adenomyosis indicates pathogenic effects of the proposed treatment. At the same time in patients with adenomyosis II-III degree was observed with highly bloodstream, indicating the deterioration of blood flow in the uterine vascular basin, as evidenced by some of hemostasis. Thus, studies have provided credible evidence pathogenesis mediated relations between the characteristics of the circulation of the uterus, the processes of neoangiogenesis, proliferation in the myometrium and the extent of spread of the disease, which will choose the appropriate methods of conservative treatment. Using drugs and Indinol epigallat affecting the basic pathogenetic mechanisms of adenomyosis, opens a new direction in the treatment of this disease, and effective natural methods - new opportunities in the treatment of adenomyosis.
- 15 September 2016
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 7 (3) , 92-97
Open AccessContemporary aspects of pathogenetically substantiated therapy of adenomyosis
The purpose of our study was to assess the effectiveness of the use of drugs containing indole-3-carbinol and epigallocatechin-3 gallate in combination with effective natural methods (TES-therapy and hirudotherapy) depending on the degree of morphological adenomyosis. The study involved 205 women with diffuse adenomyosis. Based on survey data from 205 women surveyed in 67 verified adenomyosis first degree (Group 1), 79 - second degree adenomyosis (group 2), and 59 - third degree adenomyosis (group 3). Doppler results showed that in patients with adenomyosis first degree nizkorezistentny uterine blood flow was observed. Improvement of clinical symptoms of the disease, increasing the numerical values of R & D in the uterine arteries at the first degree adenomyosis indicates pathogenic effects of the proposed treatment. At the same time in patients with adenomyosis II-III degree was observed with highly bloodstream, indicating the deterioration of blood flow in the uterine vascular basin, as evidenced by some of hemostasis. Thus, studies have provided credible evidence pathogenesis mediated relations between the characteristics of the circulation of the uterus, the processes of neoangiogenesis, proliferation in the myometrium and the extent of spread of the disease, which will choose the appropriate methods of conservative treatment. Using drugs and Indinol epigallat affecting the basic pathogenetic mechanisms of adenomyosis, opens a new direction in the treatment of this disease, and effective natural methods - new opportunities in the treatment of adenomyosis.